Antioxidants and human diseases

Clinica Chimica Acta

Volumn 436, Issue , 2014, Pages 332-347

  Rajendran, Peramaiyan ^a   Nandakumar, Natarajan ^b   Rengarajan, Thamaraiselvan ^a   Palaniswami, Rajendran ^d   Gnanadhas, Edwinoliver Nesamony ^b   Lakshminarasaiah, Uppalapati ^c   Gopas, Jacob ^b,c   Nishigaki, Ikuo ^a  

^a NPO International Laboratory of Biochemistry   (Japan)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d Vivekananda College   (India)

Author keywords

Antioxidant; Cancer; Diabetes; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; COPPER; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; HYPOCHLORITE; LIPID PEROXIDE; LYCOPENE; MANGANESE; POLYPHENOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SELENIUM; SINGLET OXYGEN; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOL; XANTHINE OXIDASE; ZINC; ANTIOXIDANTS; BIOLOGICAL MARKERS;

ANTIOXIDANT ACTIVITY; ARTHRITIS; CARDIOVASCULAR DISEASE; CELL CYCLE PROGRESSION; CELL DEATH; CELL DIFFERENTIATION; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE MARKER; DISEASES; DNA DAMAGE; ENZYME ACTIVITY; HUMAN; JOINT STIFFNESS; MOLECULAR PATHOLOGY; NEOPLASM; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; DISEASE; FOOD; HUMANS; METABOLISM;

ANTIOXIDANTS; BIOLOGICAL MARKERS; DISEASE; FOOD; HUMANS; OXIDATIVE STRESS;

EID: 84904052451     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.06.004     Document Type: Review

References (263)

1. Dinstel R.R., Cascio J., Koukel S. The antioxidant level of Alaska's wild berries: high, higher and highest. Int J Circumpolar Health 2013, 72:796-802.
2. Pham-Huy L.A., He H., Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci 2008, 4:89-96.
3. Valko M., Leibfritz D., Moncol J., Cronin M.T.D., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84.
4. Singh P.P., Chandra A., Mahdi F., Roy A., Sharma P. Reconvene and reconnect the antioxidant hypothesis in human health and disease. Indian J Clin Biochem 2010, 25:225-243.
5. Sen S., Chakraborty R., Sridhar C., Reddy Y.S.R., De B. Free radicals, antioxidants, diseases and phytomedicines: current status and future prospect. Int J Pharm Sci Rev Res 2010, 3:91-100.
6. Lykkesfeldt J., Svendsen O. Oxidants and antioxidants in disease: oxidative stress in farm animals. Vet J 2007, 173:502-511.
7. Miller J.K., Brzezinska-Slebodzinska E., Madsen F.C. Oxidative stress, antioxidants, and animal function. J Dairy Sci 1993, 76:2812-2823.
8. Sugino N. Roles of reactive oxygen species in the corpus luteum. Anim Sci J 2006, 77:556-565.
9. Reilly P.M., Schiller H.J., Bulkley G.B. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg 1991, 161:488-503.
10. Alberti A., Bolognini L., Macciantelli D., Caratelli M. The radical cation of N, N-Diethyl-para-phenylendiamine: a possible indicator of oxidative stress in biological samples. Res Chem Intermed 2000, 26:253-267.
11. Di Trana A., Celi P., Claps S., Fedele V., Rubino R. The effect of hot season and nutrition on the oxidative status and metabolic profile in dairy goats during mid lactation. Anim Sci 2006, 82:717-722.
12. Rizzo A., Mutinati M., Spedicato M., et al. First demonstration of an increased serum level of reactive oxygen species during the peripartal period in the ewes. Immunopharmacol Immunotoxicol 2008, 30:741-746.
13. Bernabucci U., Ronchi B., Lacetera N., Nardone A. Influence of body condition score on relationships between metabolic status and oxidative stress in periparturient dairy cows. J Dairy Sci 2005, 88:2017-2026.
14. Merlo M., Celi P., Barbato O., Gabai G. Relationships between oxidative status and pregnancy outcome in dairy cows. Anim Prod Aust 2008, 27:84.
15. Celi P., Sullivan M., Evans D. The stability of the reactive oxygen metabolites (d-ROMs) and biological antioxidant potential (BAP) tests on stored horse blood. Vet J 2010, 183:217-218.
16. Fialová L., Malbohan I., Kalousová M., et al. Oxidative stress and inflammation in pregnancy. Scand J Clin Lab Invest 2006, 66:121-127.
17. Noyan T., Güler A., Sekeroglu M.R., Kamaci M. Serum advanced oxidation protein products, myeloperoxidase and ascorbic acid in pre-eclampsia and eclampsia. Aust N Z J Obstet Gynaecol 2006, 46:486-491.
18. Witko-Sarsat V., Friedlander M., Nguyen Khoa T., et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998, 161:2524-2532.
19. Kalousová M., Skrha J., Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002, 51:597-604.
20. Shi X.Y., Hou F.F., Niu H.X., et al. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology 2008, 149:1829-1839.
21. Kaneda H., Taguchi J., Ogasawara K., Aizawa T., Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 2002, 162:221-225.
22. Atabek M.E., Keskin M., Yazici C., et al. Protein oxidation in obesity and insulin resistance. Eur J Pediatr 2006, 165:753-756.
23. Celi P., Raadsma H.W. The effects of Yerba Mate (Ilex paraguarensis) supplementation on the productive performance of lambs. Proceeding of the XIth International Symposium in Ruminant Physiology 2009, 804-805. Clermont-Ferrand, France.
24. Celi P., Raadsma H.W. Effects of Yerba Mate (Ilex paraguariensis) supplementation on the productive performance of dairy cows during mid-lactation. Anim Prod Sci 2010, 50:339-344.
25. Kalousová M., Zima T., Tesar V., Dusilová-Sulková S., Skrha J. Advanced glycoxidation end products in chronic diseasesclinical chemistry and genetic background. Mutat Res 2005, 579:37-46.
26. Witko-Sarsat V., Nguyen-Khoa T., Jungers P., Drüeke T.B., Descamps-Latscha B. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia. Nephrol Dial Transplant 1999, 14(1):76-78.
27. Merlo M., Barbato O., Stefani A., Celi P., Da Dalt L., Gabai G. Embryonic mortality and plasma advanced oxidation protein products (AOPP) increase in dairy cows. Current Topics in Dairy Production, Proceedings of the Dairy Research Foundation Symposium 2008, 49-53. SciELO Brazil, [Camden, Australia].
28. Georgieva N.V. Oxidative stress as a factor of disrupted ecological oxidative balance in biological systems-a review. Bulg J Vet Med 2005, 8:1-11.
29. Janero D.R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990, 9:515-540.
30. Halliwell B., Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993, 57:715S-724S.
31. Castillo C., Hernández J., Valverde I., et al. Plasma malonaldehyde (MDA) and total antioxidant status (TAS) during lactation in dairy cows. Res Vet Sci 2006, 80:133-139.
32. Bouwstra R.J., Goselink R.M., Dobbelaar P., Nielen M., Newbold J.R., van Werven T. The relationship between oxidative damage and vitamin E concentration in blood, milk, and liver tissue from vitamin E supplemented and nonsupplemented periparturient heifers. J Dairy Sci 2008, 91:977-987.
33. Griffiths H.R., Moller L., Bartosz G., et al. Biomarkers. Mol Aspects Med 2002, 23:101-208.
34. Lykkesfeldt J. Determination of malondialdehyde as dithiobarbituric acid adduct in biological samples by HPLC with fluorescence detection: comparison with ultraviolet-visible spectrophotometry. Clin Chem 2001, 47:1725-1727.
35. Milne G.L., Musiek E.S., Morrow J.D. F2-Isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 2005, 10:10-23.
36. Mohanty J.G., Bhamidipaty S., Evans M.K., Rifkind J.M. A fluorimetric semi-microplate format assay of protein carbonyls in blood plasma. Anal Biochem 2010, 400(2):289-294.
37. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95(2):351-358.
38. Collins C.E., Quaggiotto P., Wood L., O'Loughlin E.V., Henry R.L., Garg M.L. Elevated plasma levels of F2α isoprostane in cystic fibrosis. Lipids 1999, 6(34):551-556.
39. Halliwell B., Gutteridge J.M.C. Free radical in biology and medicine 2007, Oxford University Press, New York, NY, USA. 4th ed.
40. Benzie I.F.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996, 239(1):70-76.
41. Roe H.J., Kuether C.A. Detection of ascorbic acid in whole blood and urine through the 2, 4-dinitrophenyl-hydrazine derivative of dehydro ascorbic acid. J Biol Chem 1943, 147:399-407.
42. Teissier E., Walters-Laporte E., Duhem C., Luc G., Fruchart J.C., Duriez P. Rapid quantification of alpha-tocopherol in plasma and low- and high-density lipoproteins. Clin Chem 1996, 42(1):430-435.
43. Misra H.P., Fridovich I. Therole of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972, 247(10):3170-3175.
44. Aebi M. Catalase. Methods of enzymatic analysis 1974, vol. 2. Verlag Chemie-Academic Press, NY, USA. H.U. Bergmeyer (Ed.).
45. Flohe L., Gunzler W.A. Assays of glutathione peroxidise. Met Enzymol 1984, 105:114-120.
46. Hissin P.J., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976, 74(1):214-226.
47. Haining J.L., Legan J.S. Fluorometric assay for xanthine oxidase. Anal Biochem 1967, 21(3):337-343.
48. Nauseef W.M. Biological roles for the NOX family NADPH oxidases. J Biol Chem 2008, 283(25):16961-16965.
49. Burger D., Touyz R.M. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J Am Soc Hypertens 2012, 6(2):85-99.
50. Touyz R.M., Schiffrin E. Arterial hypertension. Muscle fundamental biology and mechanisms of disease 2012, vol. 2:1311-1319. Elsevier, San Diego, Calif, USA. J. Hill (Ed.).
51. Sinha M.K., Gaze D.C., Tippins J.R., Collinson P.O., Kaski J.C. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003, 107(19):2403-2405.
52. Kohen R., Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 2002, 30(6):620-650.
53. Scholz R.W., Graham K.S., Gumpricht E., Reddy C.C. Mechanism of interaction of vitamin E and glutathione in the protection against membrane lipid peroxidation. Ann N Y Acad Sci 1989, 570:514-517.
54. Harrison R. Structure and function of xanthine oxidoreductase: where are we now?. Free Radic Biol Med 2002, 33(6):774-797.
55. Yamazaki T., Kawai C., Yamauchi A., Kuribayashi F. A highly sensitive chemiluminescence assay for superoxide detection and chronic granulomatous disease diagnosis. Trop Med Health 2011, 39(2):41-45.
56. Nauseff W.M. Detection of superoxide anion and hydrogen peroxide production by cellular NADPH oxidases. Biochim Biophys Acta 2014, 1840(2):757-767.
57. Moller P., Loft S. Dietary antioxidants and beneficial effect on oxidatively damaged DNA. Free Radic Biol Med 2006, 41:388-415.
58. Moller P. The alkaline comet assay: towards validation in biomonitoring of DNA damaging exposures. Basic Clin Pharmacol Toxicol 2006, 98:336-345.
59. Boyle S.P., Dobson V.L., Duthie S.J., Kyle J.A.M., Collins A.R. Absorption and protective effects of flavonoid glycosides from an onion meal. Eur J Nutr 2000, 39:213-223.
60. Moller P., Loft S. Oxidative DNA damage in white blood cells of humans in dietary antioxidant intervention studies. Am J Clin Nutr 2002, 76:303-310.
61. Sacheck J.M., Milbury P.E., Cannon J.G., Roubenoff R., Blumberg J.B. Effect of vitamin E and eccentric exercise on selected biomarkers of oxidative stress in young and elderly men. Free Radic Biol Med 2003, 34:1575-1588.
62. Collins A.R., Cadet J., Moller L., Poulsen H.E., Vina J. Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells?. Arch Biochem Biophys 2004, 423:57-65.
63. Arendt B.M., Ellinger S., Kekic K., et al. Single and repeated moderate consumption of native or dealcoholized red wine show different effects on antioxidant parameters in blood and DNA strand breaks in peripheral leukocytes in healthy volunteers: a randomized controlled trial (ISRCTN68505294). Nutr J 2005, 4:33.
64. Collins A.R., Duthie S.J., Dobson V.L. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 1993, 14:1733-1735.
65. Foksinski M., Rozalski R., Guz J., et al. Urinary excretion of DNA repair products correlates with metabolic rates as well as with maximum life spans of different mammalian species. Free Radic Biol Med 2004, 37:1449-1454.
66. Collins A.R. Assays for oxidative stress and antioxidant status: applications to research into the biological effectiveness of polyphenols. Am J Clin Nutr 2005, 81:261S-267S.
67. Bowen P., Chen L., Stacewicz-Sapuntzakis M., et al. Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp Biol Med 2002, 227:886-893.
68. Collins A.R., Gedik C.M., Olmedilla B., Southon S., Bellizzi M. Oxidative DNA damage measured in human lymphocytes: large differences between sexes and between countries, and correlations with heart disease mortality rates. FASEB J 1998, 12:1397-1400.
69. Moller P., Loft S. Interventions with antioxidants and nutrients in relation to oxidative DNA damage and repair. Mutat Res 2004, 551:79-89.
70. Choi S.W., Benzie I.F., Collins A.R., Hannigan B.M., Strain J.J. Vitamins C and E: acute interactive effects on biomarkers of antioxidant defence and oxidative stress. Mutat Res 2004, 551:109-117.
71. Tsilimigaki S., Messini-Nikolaki N., Kanariou M., Piperakis S.M. A study on the effects of seasonal solar radiation on exposed populations. Mutagenesis 2003, 18:139-143.
72. Panayiotidis M., Collins A.R. Ex vivo assessment of lymphocyte antioxidant status using the comet assay. Free Radic Res 1997, 27:533-537.
73. Moller P., Vogel U., Pedersen A., Dragsted L.O., Sandstrom B., Loft S. No effect of 600g fruit and vegetables per day on oxidative DNA damage and repair in healthy human non-smokers. Cancer Epidemiol Biomarkers Prev 2003, 12:1016-1022.
74. Moller P., Viscovich M., Lykkesfeldt J., Loft S., Jensen A., Poulsen H.E. Vitamin C supplementation decreases oxidative DNA damage in mononuclear blood cells of smokers. Eur J Nutr 2004, 43:267-274.
75. Giovannelli L., Saieva C., Masala G., et al. Nutritional and lifestyle determinants of DNA oxidative damage: a study in a Mediterranean population. Carcinogenesis 2002, 23:1483-1489.
76. Gedik C.M., Collins A. ESCODD (European Standards Committee on Oxidative DNA Damage). Establishing the background level of base oxidation in human lymphocyte DNA: results of an inter-laboratory validation study. FASEB J 2005, 19:82-84.
77. Françoise D.G., Chantal M.B. The many faces of endothelial microparticles. Arter Throm Vasc Bio 2011, 31:27-33.
78. Eguchi M., Monden K., Miwa N. Role of MAPK phosphorylation in cytoprotection by pro-vitamin C against oxidative stress-induced injuries in cultured cardiomyoblasts and perfused rat heart. J Cell Biochem 2003, 90:219-226.
79. Nguyen H.T., Hsieh M.H., Gaborro A., Tinloy B., Phillips C., Adam R.M. JNK/SAPK and p38 SAPK-2 mediate mechanical stretch-induced apoptosis via caspase-3 and-9 in NRK-52E renal epithelial cells. Nephron Exp Nephrol 2006, 102:49-61.
80. Matsuzawa A., Ichijo H. Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim Biophys Acta Gen Subj 2008, 1780:1325-1336.
81. Torres M. Mitogen-activated protein kinase pathways in redox signaling. Front Biosci 2003, 8:D369-D391.
82. Donadelli M., DallaPozza E., Costanzo C., Scupoli M.T., Piacentini P., Scarpa A. Increased stability of P21(WAF1/CIP1) mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidinedithiocarbamate. Biochim Biophys Acta 2006, 1763:917-926.
83. Hsu W.H., Hsieh Y.S., Kuo H.C., et al. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL. Arch Toxicol 2007, 81:719-728.
84. Liu Y., Borchert G.L., Surazynski A., Hu C.A., Phang J.M. Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling. Oncogene 2006, 25:5640-5647.
85. Barry I. Vitamin C: friends or foe?. Nat Rev Cancer 2008, 8:830.
86. Liu L., Zhao S.P., Gao M., Zhou Q.C.Z., Li Y.L., Xia B. Vitamin C preserves endothelial function in patients with coronary heart disease after a high-fat meal. Clin Cardiol 2002, 25:219-224.
87. Wang Y., Hodge A.M., Wluka A.E., et al. Effect of antioxidante on knee cartilage and bone in healthy, middle-aged subjects: a cross-sectional study. Arthritis Res Ther 2007, 9:1-9.
88. Wintergerst E.S., Maggini S., Homig D.H. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab 2006, 50:85-94.
89. Woo A., Kim J.H., Jeong Y.J., et al. Vitamin C acts indirectly to modulate isotype switching in mouse B cells. Anat Cell Biol 2010, 43:25-35.
90. Thankachan P., Walczyk T., Muthayya S., Kurpad A.V., Hurrell R.F. Iron absorption in young Indian women: the interaction of iron status with the influence of tea and ascorbic acid. Am J Clin Nutr 2008, 87:881-886.
91. Riso P., Martini D., Moller P., et al. DNA damage and repair activity after broccoli intake in young healthy smokers. Mutagenesis 2010, 1-8.
92. Pryor W.L. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000, 28:141-161.
93. Traber M.G., Frei B., Beckman J.S. Vitamin E revisited: do new data validate for chronic disease prevention?. Curr Opin Lipidol 2008, 19:30-38.
94. Weinstein S.J., Wright M.E., Lawson K.A., et al. Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007, 16:1253-1258.
95. Muller D.P.R. Vitamin E and neurological functions. Mol Nutr Food Res 2010, 54:1-9.
96. Devore E.E., Grodstein F., van Rooij F.J., et al. Dietary antioxidant and lonterm risk of dementia. Arch Neurol 2010, 67:819-825.
97. Miyake Y., Fukushima W., Tanaka K., et al. Dietary intake of antioxidant vitamins and risk of Parkinson's disease: a case-control study in Japan. Eur J Neurol 2010, 10.1111/j.1468-1331.2010. 03088.
98. Manach C., Mazur A., Scalbert A. Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol 2005, 16:77-84.
99. Russo P., Tedesco I., Russo M., Russo G.L., Venezia A., Cicala C. Effects of de-alcoholated red wine and its phenolic fractions on platelet aggregation. Nutr Metab Cardiovasc Dis 2001, 11:25-29.
100. Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000, 101:1899-1906.
101. Corder R., Mullen W., Khan N.Q., et al. Oenology: red wine procyanidins and vascular health. Nature 2006, 444:566.
102. Yang C.S., Landau J.M., Huang M.T., Newmark H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Ann Rev Nutr 2001, 21:381-406.
103. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001, 18:685-716.
104. Pan T., Jankovic J., Le W. Potential therapeutic properties of green tea polyphenols in Parkinson's disease. Drugs Aging 2003, 20:711-721.
105. Zunino S.J., Storms D.H., Stephensen C.B. Diets rich in polyphenols and vitamin A inhibit the development of Type I autoimmune diabetes in nonobese diabetic mice. J Nutr 2007, 137:1216-1221.
106. Atmaca A., Kleerekoper M., Bayraktar M., Kucuk O. Soy isoflavones in the management of postmenopausal osteoporosis. Menopause 2008, 15:748-757.
107. Hurrell R.F., Reddy M., Cook J.D. Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages. Br J Nutr 1999, 81:289-295.
108. Visioli F., Grande S., Bogani P., Galli C. The role of antioxidants in the mediterranean diets: focus on cancer. Eur J Cancer Prev 2004, 13:337-343.
109. de Oliveira El-Warrak A., Rouma M., Amoroso A., Boysen S.R., Chorfi Y. Measurement of vitamin A, vitamin E, selenium, and l-lactate in dogs with and without osteoarthritis secondary to ruptured cranial cruciate ligament. Can Vet J 2012, 53:1285-1288. [La revue veterinairecanadienne].
110. Roush J.K., McLaughlin R.M., Radlinsky M.A.G. Understanding the pathophysiology of osteoarthritis. Vet Med 2002, 97:108-117.
111. Hadjigogos K. The role of free radicals in the pathogenesis of rheumatoid arthritis. Panminerva Med 2003, 45:7-13.
112. Liu C., Russell R.M., Wang X.D. Alpha-Tocopherol and ascorbic acid decrease the production of beta-apo-carotenals and increase the formation of retinoids from beta-carotene in the lung tissues of cigarette smoke-exposed ferrets in vitro. J Nutr 2004, 134:426-430.
113. Ortiz J., Marin R., Noriega D., Navarro M., Arozarena I. Color, phenolics, and antioxidant activity of blackberry (RubusglaucusBenth.), blueberry (VacciniumfloribundumKunth.), and apple wines from Ecuador. J Food Sci 2013, 78:C985-C993.
114. Pastor-Valero M. Fruit and vegetable intake and vitamins C and E are associated with a reduced prevalence of cataract in a Spanish Mediterranean population. BMC Ophthalmol 2013, 13:52.
115. Elmali N., Baysal O., Harma A., Esenkaya I., Mizrak B. Effects of resveratrol in inflammatory arthritis. Inflammation 2007, 30:1-6.
116. Gardi C., Valacchi G. Cigarette smoke and ozone effect on murine inflammatory responses. Environmental Stressors in Biology and Medicine 2012, 104-111. G. Valacchi (Ed.).
117. Sangani R.G., Ghio A.J. Lung injury after cigarette smoking is particle related. Int J Chron Obstruct Pulmon Dis 2011, 6:191-198.
118. Moller P., Folkmann J.K., Forchhammer L., et al. Air pollution, oxidative damage to DNA, and carcinogenesis. Cancer Lett 2008, 266:84-97.
119. Lazennec G., Richmond A. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 2010, 16:133-144.
120. Rodriguez-Vita J., Lawrence T. The resolution of inflammation and cancer. Cytokine Growth Factor Rev 2010, 21:61-65.
121. Porta C., Larghi P., Rimoldi M., et al. Cellular and molecular pathways linking inflammation and cancer. Immunobiology 2009, 214:761-777.
122. Costa C., Incio J., Soares R. Angiogenesis and chronic inflammation: cause or consequence?. Angiogenesis 2007, 10:149-166.
123. Valavanidis A., Vlachogianni T., Fiotakis K., Loridas S. Pulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms. Int J Environ Res Public Health 2013, 10:3886-3907.
124. Allavena P., Sica A., Solinas G., Porta C., Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 2008, 66:1-9.
125. Benelli R., Lorusso G., Albini A., Noonan D.M. Cytokines and chemokines as regulators of angiogenesis in health and disease. Curr Pharm Des 2006, 12:3101-3115.
126. Vendramini-Costa D.B., Carvalho J.E. Molecular link mechanisms between inflammation and cancer. Curr Pharm Des 2012, 18:3831-3852.
127. Knaapen A.M., Shi T.M., Borm P.J.A., Schins R.P.F. Soluble metals as well as the insoluble particle fraction are involved in cellular DNA damage induced by particulate matter. Mol Cell Biochem 2002, 234:317-326.
128. Hsu T.C., Young M.R., Cmarik J., Colburn N.H. Activator protein 1 (AP-1)- and nuclear factor kappa B (NF-kappa B)-dependent transcriptional events in carcinogenesis. Free Radic Biol Med 2000, 28:1338-1348.
129. Dhar A., Young M.R., Colburn N.H. The role of AP-1, NF-kappa B and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol Cell Biochem 2002, 234:185-193.
130. Sethi G., Sung B., Aggarwal B.B. Nuclear factor-kB activation: from bench to bedside. Exp Biol Med 2008, 233:21-31.
131. Lee C.H., Jeon Y.T., Kim S.H., Song Y.S. NF-kappa B as a potential molecular target for cancer therapy. BioFactors 2007, 29:19-35.
132. Wang H., Cho C.H. Effect of NF-kappa B signaling on apoptosis in chronic inflammation-associated carcinogenesis. Curr Cancer Drug Targets 2010, 10:593-599.
133. Kaefer C.M., Milner J.A. The role of herbs and spices in cancer prevention. J Nutr Biochem 2008, 19:347-361.
134. Pool-Zobel B., Veeriah S., Bohmer F.D. Modulation of xenobiotic metabolising enzymes by anticarcinogens-focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat Res Fundam Mol Mech Mutagen 2005, 591:74-92.
135. Barve A., Khor T.O., Nair S., et al. gamma-Tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice. Int J Cancer 2009, 124:1693-1699.
136. Kumaraguruparan R., Seshagiri P.B., Hara Y., Nagini S. Chemoprevention of rat mammary carcinogenesis by black tea polyphenols: modulation of xenobiotic-metabolizing enzymes, oxidative stress, cell proliferation, apoptosis, and angiogenesis. Mol Carcinog 2007, 46:797-806.
137. Lee S.B., Kim C.Y., Lee H.J., Yun J.H., Nho C.W. Induction of the phase II detoxification enzyme NQO1 in hepatocarcinoma cells by lignans from the fruit of Schisandrachinensis through nuclear accumulation of Nrf2. Planta Med 2009, 75:1314-1318.
138. Acharya A., Das I., Chandhok D., Saha T. Redox regulation in cancer a double-edged sword with therapeutic potential. Oxidative Med Cell Longev 2010, 3:23-34.
139. Huang F., Nie C., Yang Y., et al. Selenite induces redox-dependent Bax activation and apoptosis in colorectal cancer cells. Free Radic Biol Med 2009, 46:1186-1196.
140. Mebratu Y., Tesfaigzi Y. How ERK1/2 activation controls cell proliferation and cell death is subcellular localization the answer?. Cell Cycle 2009, 8:1168-1175.
141. McCubrey J.A., Steelman L.S., Abrams S.L., et al. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. Leukemia 2008, 22:708-722.
142. Tsanko S., Gechev S., Frank V.B., Julie M.S., Iliya D., Christophe L. Reactive oxygen species as signals that modulate plant stress responses and programmed cell death. Bio Essays 2006, 28:1091-1101.
143. Moran B., David E., Alexander L. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep. 2002, 3(5):420-425.
144. Asha A., Ila D., Des C., Tapas S. Redox regulation in cancer, A double-edged sword with therapeutic potential. Oxid Med Cell Longev 2010, 3(1):23-34.
145. McCubrey J.A., Lahair M.M., Franklin R.A. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 2006, 8(9-10):1775-1789.
146. Christodoulou M.I., Kontos C.K., Halabalaki M., Skaltsounis A.L., Scorilas A. Nature promises new anticancer agents: interplay with the apoptosis-related BCL2 gene family. Anticancer Agents Med Chem 2014, 14(3):375-399.
147. Young J.S. NF-κB and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities. Asia Pac J Clin Nutr 2008, 17(S1):269-272.
148. Nguyen T., Nioi P., Pickett C.B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 2009, 284:13291-13295.
149. Dhakshinamoorthy S., Jaiswal A.K. Small Maf (MafG and MafK) proteins negatively regulate antioxidant response element-mediated expression and antioxidant induction of the NAD(P)H : quinone oxidoreductase1 gene. J Biol Chem 2000, 275:40134-40141.
150. Li W., Kong A.N. Molecular mechanisms of Nrf2-mediated antioxidant response. Mol Carcinog 2009, 48:91-104.
151. Kensler T.W., Wakabayashi N. Nrf2: friend or foe for chemoprevention?. Carcinogenesis 2010, 31:90-99.
152. Singh B., Bhat N.K., Bhat H.K. Induction of NAD(P)H-quinoneoxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer. Carcinogenesis 2012, 33:156-163.
153. Lee J.S., Surh Y.J. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett 2005, 224:171-184.
154. Yu X., Kensler T. Nrf2 as a target for cancer chemoprevention. Mutat Res Fundam Mol Mech Mutagen 2005, 591:93-102.
155. Clemens M.R., Ladner C., Schmidt H., et al. Decreased essential antioxidants and increased lipid hydroperoxides following high-dose radiochemotherapy. Free Radic Res Commun 1989, 7:227-232.
156. Clemens M.R., Waladkhani A.R., Bublitz K., Ehninger G., Gey K.F. Supplementation with antioxidants prior to bone marrow transplantation. Wien Klin Wochenschr 1997, 109:771-776.
157. Hunnisett A., Davies S., McLaren-Howard J., Gravett P., Finn M., Gueret-Wardle D. Lipoperoxides as an index of free radical activity in bone marrow transplant recipients. Preliminary observations. Biol Trace Elem Res 1995, 47:125-132.
158. Lloyd J.V., Davis P.S., Emery H., Lander H. Platelet ascorbic acid levels in normal subjects and in disease. J Clin Pathol 1972, 25:478-483.
159. Sundström H., Korpela H., Viinikka L., Kauppila A. Serum selenium and glutathione peroxidase, and plasma lipid peroxides in uterine, ovarian or vulvar cancer, and their responses to antioxidants in patients with ovarian cancer. Cancer Lett 1984, 24:1-10.
160. Jaakkola K., Lähteenmäki P., Laakso J., Harju E., Tykkä H., Mahlberg K. Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with small-cell lung cancer. Anticancer Res 1992, 12:599-606.
161. Lockwood K., Moesgaard S., Hanioka T., Folkers K. Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol Aspects Med 1994, 15:s231-s240.
162. Ladas Elena J., Jacobson Judith S., Kennedy Deborah D., Teel Katherine, Fleischauer Aaron, Kelly Kara M. Antioxidants and cancer therapy: a systematic review. J Clin Oncol 2004, 22:517-528.
163. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
164. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003, 17:24-38.
165. Nishigaki I., Rajendran P., Venugopal R., Ekambaram G., Sakthisekaran D., Nishigaki Y. Cytoprotective role of astaxanthin against glycated protein/iron chelate-induced toxicity in human umbilical vein endothelial cells. Phytother Res 2010, 24:54-59.
166. Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010, 107:1058-1070.
167. Avignon A., Hokayem M., Bisbal C., Lambert K. Dietary antioxidants: do they have a role to play in the ongoing fight against abnormal glucose metabolism?. Nutrition 2012, 28:715-721.
168. Ceriello A., Morocutti A., Mercuri F., et al. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 2000, 49:2170-2177.
169. DeRubertis F.R., Craven P.A., Melhem M.F. Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol. Metab Clin Exp 2007, 56:1256-1264.
170. Hinerfeld D., Traini M.D., Weinberger R.P., et al. Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice. J Neurochem 2004, 88:657-667.
171. Nishikawa T., Edelstein D., Du X.L., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
172. Asaba K., Tojo A., Onozato M.L., Goto A., Fujita T. Double-edged action of SOD mimetic in diabetic nephropathy. J Cardiovasc Pharmacol 2007, 49:13-19.
173. Mollsten A., Marklund S.L., Wessman M., et al. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes 2007, 56:265-269.
174. de Haan J.B., Stefanovic N., Nikolic-Paterson D., et al. Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy. Am J Physiol Ren Physiol 2005, 289:F544-F551.
175. Brezniceanu M.L., Liu F., Wei C.C., et al. Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int 2007, 71:912-923.
176. dos Santos K.G., Canani L.H., Gross J.L., Tschiedel B., PiresSouto K.E., Roisenberg I. The catalase-262C/T promoter polymorphism and diabetic complications in Caucasians with type 2 diabetes. Dis Markers 2006, 22:355-359.
177. Kunisaki M., Bursell S.E., Clermont A.C., et al. Vitamin-E prevents diabetes-induced abnormal retinal blood-flow via the diacylglycerol-protein kinase-C pathway. Am J Physiol Endocrinol Metab 1995, 269:E239-E246.
178. Mohora M., Greabu M., Muscurel C., Duţa C., Totan A. The sources and the targets of oxidative stress in the etiology of diabetic complications. Rom J Biophys 2007, 17:63-84.
179. Obrosova I.G., Fathallah L., Greene D.A. Early changes in lipid peroxidation and antioxidativedefense in diabetic rat retina: effect of dl-alpha-lipoic acid. Eur J Pharmacol 2000, 398:139-146.
180. Hong J.H., Kim M.J., Park M.R., et al. Effects on vitamin E on oxidative stress and membrane fluidity brain of streptozotocin-induced diabetic rats. Clin Chim Acta 2004, 340:107-115.
181. Coleman M.D., Fernandes S., Khanderia L. A preliminary evaluation of a novel method to monitor a triple antioxidant combination (vitamins E, C and alpha-lipoic acid) in diabetic volunteers using in vitro methaemoglobin formation. Environ Toxicol Pharmacol 2003, 14:69-75.
182. Panjwani U., Yadav D.K., Kumar A., Singh S.B., Selvamurthy W. Effect of vitamin C and E supplementation in modulating the peripheral nerve conduction following cold exposure in humans. Int J Biometeorol 2003, 48:103-107.
183. Sivan E., Reece E.A., Wu Y.K., Homko C.J., Polansky M., Borenstein M. Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis. Am J Obstet Gynecol 1996, 175:793-799.
184. Chang T.I., Horal M., Jain S.K., Wang F., Patel R., Loeken M.R. Oxidant regulation of gene expression and neural tube development: insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia 2003, 46:538-545.
185. Otero P., Bonet B., Herrera E., Rabano A. Development of atherosclerosis in the diabetic BALB/c mice-prevention with Vitamin E administration. Atherosclerosis 2005, 182:259-265.
186. Hayek T., Kaplan M., Kerry R., Aviram M. Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: a stimulatory role for d-glucose. Atherosclerosis 2007, 195:277-286.
187. Reaven P.D., Herold D.A., Barnett J., Edelman S. Effects of vitamin-E on susceptibility of low-density-lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in niddm. Diabetes Care 1995, 18:807-816.
188. Salonen J.T., Ylaherttuala S., Yamamoto R., et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 1992, 339:883-887.
189. Bantle J.P., Wylie-Rosett J., Albright A.L., et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008, 31(1):S61-S78.
190. Landmesser U., Drexler H. General concepts about oxidative stress. Dev Cardiovasc Med 2006, 258:1-15.
191. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993, 91:2546-2551.
192. Hink U., Li H.G., Mollnau H., et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001, 88:E14-E22.
193. Victor V.M., Rocha M., Sola E., Banuls C., Garcia-Malpartida K., Hernandez-Mijares A. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr Pharm Des 2009, 15:2988-3002.
194. Sugamura K., Keaney J.F. Reactive oxygen species in cardiovascular disease. Free Radic Biol Med 2011, 51:978-992.
195. Libby P., Ridker P.M., Hansson G.K. Leducq Transatlantic Network A. Inflammation in atherosclerosis from pathophysiology to practice. J Am Coll Cardiol 2009, 54:2129-2138.
196. Fuhrman B., Volkova N., Aviram M. Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase. Atherosclerosis 2002, 161:307-316.
197. Shirpoor A., Ansari M.-H.K., Heshmatian B., et al. Decreased blood pressure with a corresponding decrease in adhesive molecules in diabetic rats caused by vitamin E administration. J Diabetes 2012, 4:362-368.
198. Saeed R.W., Peng T., Metz C.N. Ascorbic acid blocks the growth inhibitory effect of tumor necrosis factor-alpha on endothelial cells. Exp Biol Med 2003, 228:855-865.
199. Rossig L., Hoffmann J., Hugel B., et al. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation 2001, 104:2182-2187.
200. Libby P., Aikawa M. Vitamin C, collagen, and cracks in the plaque. Circulation 2002, 105:1396-1398.
201. Axelrad T.W., Deo D.D., Ottino P., et al. Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration. FASEB J 2004, 18:568-570.
202. Yoshikawa K., Takahashi S., Imamura Y., Sado Y., Hayashi T. Secretion of non-helical collagenous polypeptides of alpha 1(IV) and alpha 2(IV) chains upon depletion of ascorbate by cultured human cells. J Biochem 2001, 129:929-936.
203. Kawashima S., Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 2004, 24:998-1005.
204. Heller R., Unbehaun A., Schellenberg B., Mayer B., Werner-Felmayer G., Werner E.R. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 2001, 276:40-47.
205. Gao F., Yao C.L., Gao E.H., et al. Enhancement of glutathione cardioprotection by ascorbic acid in myocardial reperfusion injury. J Pharmacol Exp Ther 2002, 301:543-550.
206. Vink H., Constantinescu A.A., Spaan J.A.E. Oxidized lipoproteins degrade the endothelial surface layer-implications for platelet-endothelial cell adhesion. Circulation 2000, 101:1500-1502.
207. Fukai T., Siegfried M.R., Ushio-Fukai M., Cheng Y., Kojda G., Harrison D.G. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest 2000, 105:1631-1639.
208. Narang D., Sood S., Thomas M.K., Dinda A.K., Maulik S.K. Effect of dietary palm olein oil on oxidative stress associated with ischemic-reperfusion injury in isolated rat heart. BMC Pharmacol 2004, 4:29.
209. Das S., Powell S.R., Wang P., et al. Cardioprotection with palm tocotrienol: antioxidant activity of tocotrienol is linked with its ability to stabilize proteasomes. Am J Physiol Heart Circ Physiol 2005, 289:H361-H367.
210. Carlson D., Maass D.L., White D.J., Tan J., Horton J.W. Antioxidant vitamin therapy alters sepsis-related apoptotic myocardial activity and inflammatory responses. Am J Physiol Heart Circ Physiol 2006, 291:H2779-H2789.
211. Tian N., Moore R.S., Braddy S., et al. Interactions between oxidative stress and inflammation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol 2007, 293:H3388-H3395.
212. Papparella I., Ceolotto G., Berto L., et al. Vitamin C prevents zidovudine-induced NAD(P)H oxidase activation and hypertension in the rat. Cardiovasc Res 2007, 73:432-438.
213. Matejikova J., Kucharska J., Pancza D., Ravingerova T. The effect of antioxidant treatment and NOS inhibition on the incidence of ischemia-induced arrhythmias in the diabetic rat heart. Physiol Res/Acad Sci Bohem 2008, 57:S55-S60.
214. Chu Y., Iida S., Lund D.D., et al. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ Res 2003, 92:461-468.
215. Sentman M.L., Brannstrom T., Westerlund S., et al. Extracellular superoxide dismutase deficiency and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2001, 21:1477-1482.
216. Yang H., Roberts L.J., Shi M.J., et al. Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ Res 2004, 95:1075-1081.
217. van Empel V.P., Bertrand A.T., van Oort R.J., et al. EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant. J Am Coll Cardiol 2006, 48:824-832.
218. Blankenberg S., Rupprecht H.J., Bickel C., et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 2003, 349:1605-1613.
219. Forgione M.A., Weiss N., Heydrick S., et al. Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am J Physiol Heart Circ Physiol 2002, 282:H1255-H1261.
220. Kisucka J., Chauhan A.K., Patten I.S., et al. Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis. Circ Res 2008, 103:598-605.
221. Choi M.H., Lee I.K., Kim G.W., et al. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 2005, 435:347-353.
222. Park J.G., Yoo J.Y., Jeong S.J., et al. Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice. Circ Res 2011, 109:739-749.
223. Guo X., Yamada S., Tanimoto A., et al. Overexpression of peroxiredoxin 4 attenuates atherosclerosis in apolipoprotein E knockout mice. Antioxid Redox Signal 2012, 17:1362-1375.
224. Wei Y., Liu X.M., Peyton K.J., et al. Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival. Am J Physiol Cell Physiol 2009, 297:C907-C915.
225. Li C., Hossieny P., Wu B.J., Qawasmeh A., Beck K., Stocker R. Pharmacologic induction of heme oxygenase-1. Antioxid Redox Signal 2007, 9:2227-2239.
226. Gilgun-Sherki Y., Melamed E., Offen D. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 2001, 40:959-975.
227. Salganik R.I. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 2001, 20:464S-472S.
228. Ho Y.S., Xiong Y., Ma W.C., Spector A., Ho D.S. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem 2004, 279:32804-32812.
229. Meister A. Mitochondrial changes associated with glutathione deficiency. Biochim Biophys Acta Mol Basis Dis 1995, 1271:35-42.
230. DarleyUsmar V., Halliwell B. Blood radicals-reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm Res 1996, 13:649-662.
231. Hansen J.M., Go Y.M., Jones D.P. Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. Annu Rev Pharmacol Toxicol 2006, 215-234.
232. Schulz J.B., Lindenau J., Seyfried J., Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 2000, 267:4904-4911.
233. Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med 1999, 27:916-921.
234. Meister A., Anderson M.E. Glutathione. Annu Rev Biochem 1983, 52:711-760.
235. Sultana R., Butterfield D.A. Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products. Neurochem Res 2004, 29:2215-2220.
236. Renes J., De Vries E.E.G., Hooiveld G., Krikken I., Jansen P.L.M., Muller M. Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal. Biochem J 2000, 350:555-561.
237. Nies A.T., Jedlitschky G., Konig J., et al. Expression and immunolocalization of the multidrug resistance proteins, Mrp1-Mrp6 (ABCC1-ABCC6), in human brain. Neuroscience 2004, 129:349-360.
238. Conseil G., Deeley R.G., Cole S.P.C. Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters. Pharmacogenet Genomics 2005, 15:523-533.
239. Lovell M.A., Xie C., Markesbery W.R. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 1998, 51:1562-1566.
240. Schipper H.M., Bennett D.A., Liberman A., et al. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging 2006, 27:252-261.
241. Raina A.K., Templeton D.J., Deak J.C., Perry G., Smith M.A. Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease. Redox Rep 1999, 4:23-27.
242. Ramsey C.P., Glass C.A., Montgomery M.B., et al. Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol 2007, 66:75-85.
243. Butterfield D.A., Drake J., Pocernich C., Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med 2001, 7:548-554.
244. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997, 23:134-147.
245. Lovell M.A., Xie C., Markesbery W.R. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 2001, 22:187-194.
246. Markesbery W.R., Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 1998, 19:33-36.
247. Lauderback C.M., Hackett J.M., Huang F.F., et al. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of A beta 1-42. J Neurochem 2001, 78:413-416.
248. Kanninen K., Malm T.M., Jyrkkanen H.-K., et al. Nuclear factor erythroid 2-related factor 2 protects against beta amyloid. Mol Cell Neurosci 2008, 39:302-313.
249. Resende R., Moreira P.I., Proenca T., et al. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 2008, 44:2051-2057.
250. Martinez R.C.R., Hamani C., de Carvalho M.C., et al. Intraoperative dopamine release during globuspallidusinternus stimulation in Parkinson's disease. Mov Disord 2013, 28:2027-2031.
251. Passamonti L., Salsone M., Toschi N., et al. Dopamine-transporter levels drive striatal responses to apomorphine in Parkinson's disease. Brain Behav 2013, 3:249-262.
252. Agid Y., Ruberg M., Javoy-Agid F., et al. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?. Advances in Neurology; Parkinson's Disease: From basic research to treatment 1993, 148-164. H. Narabayashi, T. Nagatsu, N. Yanagisawa, Y. Mizuno (Eds.).
253. Smeyne M., Smeyne R.J. Glutathione metabolism and Parkinson's disease. Free Radic Biol Med 2013, 62:13-25.
254. Smith T.S., Parker W.D., Bennett J.P. L-dopa increases nigral production of hydroxyl radicals in-vivo-potential l-dopa toxicity. Neuroreport 1994, 5:1009-1011.
255. Wick M.M., Byers L., Frei E. l-dopa-selective toxicity for melanoma cells invitro. Science 1977, 197:468-469.
256. Hunot S., Brugg B., Ricard D., et al. Nuclear translocation of NF-kappa B is increased in dopaminergic neurons of patients with Parkinson disease. Proc Natl Acad Sci U S A 1997, 94:7531-7536.
257. Blum D., Torch S., Nissou M.F., Verna J.M. 6-Hydroxydopamine-induced nuclear factor-kappaB activation in PC12 cells. Biochem Pharmacol 2001, 62:473-481.
258. Levites Y., Youdim M.B.H., Maor G., Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappa B) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 2002, 63:21-29.
259. Rajendran P., Ekambaram G., Sakthisekaran D. Cytoprotective effect of mangiferin on benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice. Basic Clin Pharmacol Toxicol 2008, 103:137-142.
260. Ganapathy E., Peramaiyan R., Rajasekaran D., Venkataraman M., Dhanapal S. Modulatory effect of naringenin on N-methyl-N'-nitro-N-nitrosoguanidine- and saturated sodium chloride-induced gastric carcinogenesis in male Wistar rats. Clin Exp Pharmacol Physiol 2008, 35:1190-1196.
261. Rajendran P., Li F., Manu K.A., et al. Gamma-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent. Br J Pharmacol 2011, 163:283-298.
262. Rengarajan T., Rajendran P., Nandakumar N., Balasubramanian M.P., Nishigaki I. Cancer preventive efficacy of marine carotenoid fucoxanthin: cell cycle arrest and apoptosis. Nutrients 2013, 5:4978-4989.
263. Nandakumar N., Rengarajan T., Balamurugan A., Balasubramanian M.P. Modulating effects of hesperidin on key carbohydrate-metabolizing enzymes, lipid profile, and mbrane-bound adenosine triphosphatases against 7,12-dimethylbenz(a)anthracene-induced breast carcinogenesis. Hum Exp Toxicol 2013, 10.1177/0960327113485252.